Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm

Clinical trial NCT02528526 · UNKNOWN

Trial details

NCT number: NCT02528526
Sponsor: University of Zurich
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms Hepatocellular Cancer Cholangiocarcinoma Colorectal Neoplasms

Start date: 2014-02-01
Primary completion: 2016-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.